FORMA Therapeutics, Inc. Announces Advancement Of Collaboration With Boehringer Ingelheim Corporation For Modulating Protein-Protein Interactions In The Treatment Of Cancer
1/9/2014 10:13:21 AM
WATERTOWN, Mass.--(BUSINESS WIRE)--FORMA Therapeutics announced today the achievement of several discovery milestones in their alliance with Boehringer Ingelheim (BI) for the discovery of novel drug candidates against protein-protein interactions (PPI) for the treatment of cancer.
Help employers find you! Check out all the jobs and post your resume.
comments powered by